Novel mediators and biomarkers of thrombosis

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 1, 2014, Pages 1-3

  Sexton, Travis ^a   Smyth, Susan S ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Inflammation; Mediators; Thrombosis

Indexed keywords

ANIMALS; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84895073579     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1034-5     Document Type: Article

References (23)

1. Coller BS (2005) Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 25:658-670
2. de Boer OJ, Li X, Teeling P et al (2013) Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost 109:290-297
3. Bahou WF (2012) Platelet systems biology using integrated genetic and proteomic platforms. Thromb Res 129(Suppl 1):S38-S45
4. Wisler JW, Becker RC (2013) Emerging paradigms in arterial thrombosis. J Thromb Thrombolysis 15(12):2329-2337
5. Clancy L, Freedman JE (2013) New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer. J Thromb Thrombolysis. doi: 10.1007/s11239-013-1001-1
6. Smyth SS, McEver RP, Weyrich AS et al (2009) Platelet functions beyond hemostasis. J Thromb Haemost 7:1759-1766
7. Modjeski KL, Morrell CN (2013) Small cells, big effects: the role of platelets in transplant vasculopathy. J Thromb Thrombolysis. doi: 10.1007/s11239-013-0999-4
8. Borissoff JI, Joosen IA, Versteylen MO, Spronk HM, ten Cate H, Hofstra L (2012) Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis. JACC Cardiovasc Imaging 5:1201-1210
9. Brummel-Ziedins KE, Everse SJ, Mann KG, Orfeo T (2013) Modeling thrombin generation: plasma composition based approach. J Thromb Thrombolysis. doi: 10.1007/s11239-013-1006-9
10. Kalz J, Ten Cate H, Spronk HM (2013) Thrombin generation and atherosclerosis. J Thromb Thrombolysis. doi: 10.1007/s11239-013-1026-5
11. Steinhubl SR, Eikelboom JW, Hylek EM, Dauerman HL, Smyth SS, Becker RC (2013) Antiplatelet therapy in prevention of cardio- and venous thromboembolic events. J Thromb Thrombolysis. doi: 10.1007/s11239-013-1023-8
12. Bain J, Oyler DR, Smyth SS, Macaulay TE (2013) Pathophysiology and pharmacologic treatment of venous thromboembolism. Curr Drug Targets [Epub ahead of print]
13. Brill A, Fuchs TA, Chauhan AK et al (2011) Von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 117:1400-1407
14. Fuchs TA, Brill A, Wagner DD (2012) Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 32:1777-1783
15. Glynn RJ, Danielson E, Fonseca FA et al (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360:1851-1861
16. Patterson KA, Zhang X, Wrobleski SK et al (2013) Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. Thromb Res 131:268-276
17. Meijer WG, Croes LM, Jenni B, Lehmicke LG, Lidstrom ME, Dijkhuizen L (1990) Characterization of Xanthobacter strains H4-14 and 25a and enzyme profiles after growth under autotrophic and heterotrophic conditions. Arch Microbiol 153:360-367
18. Yin T, Miyata T (2013) Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in Northeast Asians. J Thromb Thrombolysis. doi: 10.1007/s11239-013-1005-x
19. Lim HS, Willoughby SR, Schultz C et al (2013) Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol 61:852-860
20. Kornej J, Apostolakis S, Bollmann A, Lip GY (2013) The emerging role of biomarkers in atrial fibrillation. Can J Cardiol 29:1181-1193
21. Hijazi Z, Siegbahn A, Andersson U et al (2013) High sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circulation. doi: 10.1161/CIRCULATIONAHA.113.006286
22. Rodes-Cabau J, Dauerman HL, Cohen MG et al (2013) Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol 62(25):2349-2359
23. Rowley JW, Finn AV, French PA et al (2012) Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. Circ Cardiovasc Interv 5:296-304